Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

ASCO 2026: Sylvester Trial Tests Virus-Immunotherapy Combination for Neuroendocrine Tumors

ASCO - Researchers from Sylvester Comprehensive Cancer Center will present phase 1 trial findings testing whether the tumor-targeting virus SVV-001 can improve immunotherapy in aggressive high-grade neuroendocrine tumors. The first three dose levels showed no severe treatment-related side effects.

May 21, 2026


May 29 2026

May 28 2026

May 27 2026

May 26 2026

May 25 2026

May 22 2026

May 21 2026

May 20 2026

May 19 2026

May 18 2026

May 17 2026

May 16 2026